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Abstract 
 
Purpose We evaluated the diagnostic accuracy of attenuation corrected nuclear myocardial 
perfusion imaging (MPI) with a novel hybrid SPECT/CT device consisting of an ultrafast 
dedicated cardiac gamma camera with Cadmium-Zinc-Telluride (CZT) solid-state 
semiconductor detectors integrated on to a multislice CT scanner to detect coronary artery 
disease (CAD). Invasive coronary angiography served as standard of reference. 
Methods The study population included 66 patients (79% men; mean age 63±11 years) who 
underwent one day 99mTc-tetrofosmin pharmacologic stress/rest examination and angiography 
within 3 month. Sensitivity, specificity, positive (PPV) and negative predictive value (NPV) 
as well as accuracy of the CT x-ray based attenuation corrected CZT MPI for detection of 
CAD (≥ 50% luminal narrowing) was calculated on a per-patient base. 
Results The prevalence of angiographic CAD in the study population was 82%. Sensitivity, 
specificity, PPV, NPV and accuracy were 87%, 67%, 92%, 53% and 83%, respectively. 
Conclusions In this first report on CZT SPECT/CT MPI comparison versus angiography we 
document a high accuracy for detection of angiographically documented CAD. 
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Introduction 
 
Several types of gamma cameras have recently been introduced with semiconductor detector 
material [1] instead of the conventional sodium iodine (NaI) crystals. The Cadmium-Zinc-
Telluride (CZT) semiconductors directly convert radiation into electric signals without any of 
the steps of violet light production, transport and conversion as occurs in NaI crystals. The 
new CZT technology is extremely compact and this miniaturization has enabled different 
vendors to design a stationary array of 9 [2] to 19 [3-5] pinhole gamma cameras packed 
closely and focused on the heart. The serial alignment of 19 detectors in the camera used in 
the present study allows coverage of the entire heart at all times, rendering time-consuming 
camera rotation around the patient unnecessary. The combination of the new CZT detector 
material and the geometry with simultaneous acquisition of all views necessary for 
tomographic reconstruction complemented by innovative iterative reconstruction algorithms 
has allowed shortening of scan duration from 15 minutes down to 2-3 minutes [6]. A recent 
clinical validation study has documented an excellent comparability of the CZT device and 
SPECT results with regard to both perfusion and functional data such as ejection fraction [4]. 
Despite these remarkable refinements, the discrimination of soft-tissue artefacts from real 
perfusion defects has remained a challenge. In fact, perfusion images acquired with CZT 
detectors have recently been shown to benefit from x-ray based CT attenuation correction 
validated for a CZT detector camera [3]. Consequently, and as a result of the trend towards 
hybrid devices, a first combined CZT camera integrated on to a multislice CT camera has 
been developed (Discovery NM/CT 570c, GE Healthcare). We report here the first validation 
of CT attenuation corrected myocardial perfusion imaging (MPI) by a CZT/CT device using 
invasive coronary angiography as standard of reference. 
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Material and Methods 
 
Study population: 
A total of 66 patients underwent stress/rest MPI on a CZT/64-slice CT camera (Discovery 
NM/CT 570c, GE Healthcare) and invasive coronary angiography within 3 month of the MPI. 
Patients with non-ischemic cardiomyopathy, valvular heart disease, left bundle branch block 
or prior coronary artery bypass grafting were excluded. From all patients written informed 
consent was obtained for the use of their clinical and imaging data for research purposes as 
approved by the institutional review board (local Ethics Committee). 
 
Study protocol  
One day 99mTc-tetrofosmin stress/rest imaging protocol was applied on all patients in 
accordance with the guidelines of the European Association of Nuclear Medicine [7]. All 
patients were asked to refrain from caffeine containing food and beverages for at least 12 
hours. Pharmacological stress was induced either by standard adenosine (continuous 6-
minutes administration at 140 µg/kg per minute) or dobutamine (incrementally administered, 
starting at 5 µg/kg per minute and increasing at 1 minute intervals to a maximal dose of 60 
µg/kg per minute until 85% of the age-predicted heart rate had been achieved). 99mTc-
tetrofosmin was administered after 3 minutes of induced stress. After a waiting period of 45-
60 minutes [7] (up to 90 minutes), images were acquired using the CZT/CT camera. Rest MPI 
was subsequently acquired with the identical acquisition protocol after administration of a 
three times higher dose of 99mTc-tetrofosmin. 
 
Image acquisition 
CZT/CT camera (Discovery NM/CT 570c, GE Healthcare) scans were acquired using a 
multipinhole collimator (effective diameter aperture of 5.1 mm) and 19 stationary detectors 
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simultaneously imaging 19 different views of the heart. Each detector contains 32 x 32 
pixelated (2.46 x 2.46 mm) CZT elements. The system design allows acquisition without 
detector or collimator motion. A 10% symmetrical energy window at 140 keV was used. 
Scans with the CZT camera were acquired over 3 minutes for stress and 2 minutes for rest [6]. 
 
X-ray based attenuation maps 
All patients underwent an unenhanced 64-slice CT examination on the CT part of the hybrid 
device during a breath-hold and with prospective ECG-triggering at 75% of the R-R interval 
as previously reported in detail [3]. Briefly, after acquisition with 2.5 mm section thickness, 
0.35 s gantry rotation times and 120 kV at 200-250 mA (depending on patient’s size) 
attenuation maps were reconstructed on a Xeleris workstation (GE Healthcare) [8] with 5.0 
mm thickness with a 512 x 512 matrix and a full chest-sized adapted field of view of 50 x 50 
cm. 
 
MPI image reconstruction 
CZT/CT images were reconstructed as previously reported [4, 6] on the same workstation as 
was used for CT attenuation maps applying an iterative reconstruction algorithm with 
maximum likelihood expectation maximization (MLEM). The software Myovation for 
Alcyone (GE Healthcare) was used for analysis and a Butterworth postfilter was applied to 
the reconstructed slices. All attenuation corrected images were reconstructed in standard axes 
(short axis, vertical long axis, horizontal long axis) and polar maps of the left ventricle were 
created. 
 
MPI analysis 
Images were analyzed with a commercially available software solution (Cedars QPS/QGS; 
Cedars-Sinai Medical Center, Los Angeles, CA, USA). We assessed reversible perfusion 
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defects which were identified as previously reported [9, 10]. In summary, myocardial 
tomograms were grouped into 20 segments for each patient. Segments were graded by 
consensus of two experienced readers using following five-point scoring system (0: normal; 
1: equivocal; 2: moderate; 3: severe reduction in radioisotope uptake; and 4: absence of 
detectable tracer in a segment). A scan was scored as abnormal if two or more segments had 
stress scores ≥ 2. A reversible perfusion defect was defined as one in which a stress defect 
was associated with a rest score ≤ 1 or a stress defect score of 4 with a rest score of 2. Only 
reversible defects were considered for further analysis as ischemia-driven patient management 
is most evidence-based ascertaining best clinical practice. 
A semi-automated summed rest and summed stress score was obtained from QPS/QGS by 
adding the rest and stress scores from the 20 segments. From this, a summed difference score 
(SDS) was calculated as an index of the ischemia extent. 
 
Invasive coronary angiography 
Invasive coronary angiography was conducted according to standard techniques. A coronary 
stenosis was defined as a luminal narrowing of  ≥ 50% based on visual rather than 
quantitative evaluation, as this reflects daily clinical routine in our [11] and most 
catheterization laboratories worldwide [12]. 
 
Statistical analysis 
Sensitivity, specificity, positive (PPV), negative predictive value (NPV) and accuracy were 
calculated for MPI regarding detection of CAD (≥ 50% luminal narrowing). All statistical 
analyzes were performed using SPSS 19.0 (SPSS, Chicago, IL). 
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Results 
 
All patients successfully underwent stress/rest imaging with the CZT/CT camera and invasive 
coronary angiography within 20.3 days (range -10 to 87 days) of the MPI (MPI first in 62, 
angiography first in 4 patients). The patient characteristics are shown in Table 1. Invasive 
coronary angiography identified 139 coronary artery lesions with a luminal diameter 
narrowing ≥ 50% in 106 vessels of 54 patients. Thus, prevalence of CAD in this population 
was 82%. The administered mean doses of stress and rest of 99mTc-tetrofosmin were 335±41 
MBq (range 300-440) and 980±109 MBq (range 900-1274). Pharmacological stress was 
induced by adenosine in 59 (89%) and dobutamine in 7 (11%) patients.  
 
Per-patient comparison of MPI to invasive coronary angiography 
Visual per-patient analysis of MPI revealed 51 (77%) reversible perfusion defects, whereas 
invasive coronary angiography detected 54 patients (82%) with CAD (≥ 50% luminal 
narrowing). Per-patient the sensitivity, specificity, PPV, NPV and accuracy of CZT/CT to 
predict CAD in invasive coronary angiography was 87%, 67%, 92%, 53% and 83%, 
respectively (Fig. 1). 
 
By use of a receiver operator characteristic curve for SDS a value of 2 was identified as cut-
off for best predicting CAD in invasive coronary angiography. This yielded a sensitivity, 
specificity, PPV, NPV and accuracy of 74%, 67%, 91%, 36% and 73%, respectively (Fig. 2). 
 
 8
Discussion 
 
The present study is the first to validate myocardial perfusion imaging (MPI) by a novel  
hybrid CZT/CT device integrating a latest generation CZT gamma camera on to a 64-slice CT 
scanner using invasive coronary angiography as standard of reference. This new CZT/CT 
device allows obtaining attenuation corrected MPI using CT x-ray based attenuation maps. 
Our results document an excellent PPV (92%) and accuracy (83%) for detection of CAD (≥ 
50% luminal narrowing) using the new device by visual assessment. Automated analysis with 
a cut-off for SDS at a value of 2 yielded a slightly lower sensitivity (74%) at a comparable 
PPV (91%). 
Recent reports have evidenced that CZT cameras offer excellent image quality (Fig. 3) and 
diagnostic accuracy comparable to conventional SPECT despite reduced scan duration [2, 4, 
6]. Furthermore, CT attenuation correction for high speed MPI with CZT detectors has 
recently been validated [3], although by use of a stand-alone CT, while in the present study 
this was integrated in the hybrid device.  
Our results support the accuracy of CZT MPI for detecting CAD with a high sensitivity and 
PPV. On the other hand, however, the data for specificity and NPV are much less solid due to 
the well-known referral bias as a consequence of the awareness of SPECT MPI to rule out 
CAD as a reliable gate-keeper for invasive coronary angiography [11]. Thus, patients without 
ischemia in MPI are generally not referred to invasive coronary angiography reducing the 
number of true negative MPI findings leading to a decline in specificity overtime [13]. In 
addition, the relatively high prevalence of CAD in our study may have contributed to the 
modest NPV. Despite this phenomenon the value for specificity ranges well within the values 
reported in the literature [14]. As the assessment of true specificity of MPI is almost 
impossible, some authors have suggested the normalcy rate as surrogate of specificity and 
NPV by calculating the rate of normal MPI in patients with very low pre-test probability. We 
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were reluctant to adopt this concept as we felt that this would not provide more solid ground 
to a real life setting where patients with less than 5% pre-test probability should not undergo 
MPI according to current guidelines both from nuclear cardiology [14] as well as from 
interventional cardiologists [15]. Furthermore, the anatomic reference by invasive coronary 
angiography has been recognized to be a flawed gold standard for the functional ischemia test 
MPI [16]. Due to the improved spatial resolution of the CZT detectors a better visualization of 
non-severe perfusion defects due to endothelial dysfunction in the absence of significant CAD 
may further affect specificity of this device. In a recent large multicenter trial, invasively 
assessed fractional flow reserve in coronary lesions has revealed that the majority of coronary 
lesions with 50% to 70% narrowing do not confer any hemodynamic relevance and for 
luminal narrowing of 70% to 90% functional relevance was lacking in 40% of coronary 
lesions [17]. The specificity of CZT MPI of 67% clearly reflects this large gap between 
coronary anatomy and its pathophysiologic consequence rather than a modest performance of 
attenuation corrected CZT MPI. The ultimate metric may be outcome and with regard to 
outcome prediction by MPI the added value of attenuation correction has been recently 
established [18]. The main advancement of the new CZT cameras [19] is the more than 5-fold 
reduction in scan time [4] or activity [20] at preserved accuracy. Several other applications 
allow to take even more complete advantage of the refinements offered by the new cameras 
which may further enhance the clinical importance of MPI. Although not applied in the 
present study, the geometry of the detector array allowing acquisition of all angles 
simultaneously facilitates breath-hold triggering, which can assist in discrimination of 
artefacts from true hypoperfusion similar to attenuation correction [21]. Furthermore, left 
ventricular dyssynchrony can be assessed with a scan time of 5 minutes, which may be 
repeatedly acquired [5] to enable optimization of pacing parameters in chronic 
resynchronization treatment for heart failure. 
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In conclusion, this is the first study confirming the feasibility and clinical validity of rapid 
MPI versus invasive coronary angiography on a novel CZT/CT device, which implements 
latest semiconductor detectors, innovative reconstruction algorithms with attenuation 
correction, and compact design geometry. Our results show a high PPV and accuracy for 
detection of angiographically documented CAD. 
It could be perceived as potential limitation that we did not perform quantitative coronary 
angiography to assess lesion severity. However, in real life visual assessment is performed 
mainly for ease of use and the relevant outcome studies support the validity of expert visual 
grading [12]. In addition and as mentioned above, visualization of coronary anatomy by 
invasive coronary angiography may constitute a suboptimal gold standard while a comparison 
with conventional SPECT may appear favourable. In daily clinical routine, however, patients 
with ischemia in MPI are eventually referred for invasive angiography and, thus, comparison 
of the two methods is pertinent. Furthermore, we have included a broad range of BMI (18-41) 
without in-depth analysis with regard to its impact on image quality as well as potential 
under-/ and overcorrection by implemented attenuation correction algorithms as this would 
have been beyond the scope of the present study. 
Finally, Giorgetti et al. [22] have found differential wash-out of Tc-tetrofosmin from normal 
versus ischemic myocardial regions advocating a short interval from injection to SPECT 
scanning, whereas we used a 45-60 minutes interval (according to EANM guidelines [7]) 
allowing up to 90 minutes if logistically needed. Thus, theoretically we may have 
underestimated ischemic segments, although Giorgetti et al. based their observation on 15 
minutes versus 45 minutes, where an effect of delaying image acquisition from 60 to 90 
minutes has not been reported so far. 
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Table and Figure Captions 
 
Table 1 Patient baseline characteristics 
 
Fig. 1 Sensitivity, specificity, positive predictive value (PPV), negative predictive value 
(NPV) and accuracy of visually assessed MPI to predict angiographic coronary artery disease. 
 
Fig. 2 Sensitivity, specificity, positive predictive value (PPV), negative predictive value 
(NPV) and accuracy of SDS ≥ 2 (obtained by semi-automated analysis from QPS/QGS) to 
predict angiographic coronary artery disease. 
 
Fig. 3 MPI polar plots (left panel) showing inferior ischemia (pink area in the stress 
perfusion) and corresponding angiographic stenosis (right panel) in the right coronary artery 
(arrow). 




